omniture

Chemspec International Limited Announces First Quarter 2011 Unaudited Financial Results

2011-05-25 19:06 3752

SHANGHAI, May 25, 2011 /PRNewswire-Asia-FirstCall/ -- Chemspec International Limited (NYSE: CPC; "Chemspec" or the "Company"), a leading China-based contract manufacturer of highly-engineered specialty chemicals, today announced its unaudited financial results(1) for the first quarter ended March 31, 2011.

First Quarter 2011 Financial Highlights

  • Total sales reached RMB209.0 million (US$31.9 million), representing a decrease of 5.1% from the first quarter of 2010 and a decrease of 22.7% from the fourth quarter of 2010.
  • Gross profit totaled RMB76.8 million (US$11.7 million), representing a decrease of 20.3% and 22.2% from the first quarter of 2010 and the fourth quarter of 2010, respectively.
  • Income from operations was RMB28.4 million (US$4.3 million), representing a decrease of 52.4% and 44.9% from the first quarter of 2010 and the fourth quarter of 2010, respectively.
  • Net income attributable to the Company's shareholders was RMB22.6 million (US$3.5 million), representing a decrease of 56.8% and 50.1% from the first quarter of 2010 and the fourth quarter of 2010, respectively.
  • Basic and diluted earnings per ADS(2) were both RMB0.63 (US$0.10). Basic and diluted earnings per ADS were both RMB1.44 (US$0.21) in the first quarter of 2010. Basic and diluted earnings per ADS in the fourth quarter of 2010 were both RMB1.26 (US$0.19).

(1) Certain Renminbi (RMB) amounts in this press release have been translated into U.S. dollar (USD) solely for the convenience of the reader.  The conversion of RMB into USD in this release is based on the noon buying rate in the City of New York for cable transfers in RMB per U.S. dollar as certified for customs purposes by the Federal Reserve Bank of New York on March 31, 2011, which was RMB 6.5483 to USD1.00.  The percentages stated are calculated based on RMB.

 

 

(2) 1 ADS=60 ordinary shares

 

 

 


Dr. Jianhua Yang, Chairman and Chief Executive Officer of Chemspec, commented, "The total sales of the first quarter of 2011 was in line with the guidance we provided in April. Although the past quarter was not outstanding, especially compared with our relatively stronger performance in 2010, I want to emphasize two key factors that we value in our business. First, we have strong chemical process and development capabilities and are highly competitive compared to our global peers. Secondly, we have maintained a strong client relationship with our customers. Both factors will greatly help our business when the market demand grows."

Mr. Zixin Wang, Vice President of Finance, commented, "As the inventory level has been a concern for the management, we have closely monitored the inventory level and implemented certain measures. For the first quarter of 2011, we were able to slightly lower the inventory level. Going forward, we will continue our efforts to bring down the inventory level gradually."

First Quarter 2011 Financial Results

Total Sales

For the three months ended March 31, 2011, we generated total sales of RMB209.0 million (US$31.9 million), representing a decrease of 5.1% from the first quarter of 2010 and a decrease of 22.7% from the fourth quarter of 2010.

A strong recovery in the electronics end-market occurred in the first quarter of 2010 after the global financial crisis. However, our sales to the electronics end-market was relatively weaker in the first quarter of 2011, which caused the decline in the total sales compared with the first quarter of 2010. Compared with the fourth quarter of 2010, the decrease in our total sales was primarily attributable to seasonality, as the first quarter of each year usually has lower demand for chemicals used in the electronics end-market.

Gross Profit and Gross Margin

In the first quarter of 2011, we generated gross profit of RMB76.8 million (US$11.7 million), representing a decrease of 20.3% from the first quarter of 2010 and a decrease of 22.2% from the fourth quarter of 2010. We attribute the decreases in the gross profit primarily to the corresponding declines in the total sales in the corresponding quarters.

Our gross margin was 36.8% in the first quarter of 2011, as compared with 43.8% in the first quarter of 2010 and 36.5% in the fourth quarter of 2010. Compared with the first quarter of 2010, the gross margin decreased primarily due to a less favorable product mix in the first quarter of 2011. Compared with the fourth quarter of 2010, the gross margin slightly increased because minimal inventory was written down in the first quarter of 2011, but the effect was offset by the unfavorable product mix in the first quarter of 2011.

Operating Expenses

Selling expenses and general and administrative (SG&A) expenses were RMB36.5 million (US$5.6 million), representing an increase of 56.7% from RMB23.3 million in the first quarter of 2010 and an increase of 36.1% from RMB26.8 million in the fourth quarter of 2010. The increases were mainly attributed to the professional service fees involved in the proposed "going-private transaction", for which a Schedule 13E-3 has been filed with United States Securities and Exchange Commission ("SEC") on May 3, 2011. Going forward with the process, we expect to incur further professional service fees.

Research and development (R&D) expenses were RMB12.0 million (US$1.8 million), representing a decrease of 12.8% from RMB13.7 million in the first quarter of 2010 and a decrease of 46.0% from RMB22.1 million in the fourth quarter of 2010. The fluctuation in R&D expenses was mainly due to the change of material consumption expenses that were related to the number of active R&D projects during each period.

Income from Operations and Earnings Before Income Taxes

As a result of factors mentioned above, income from operations was RMB28.4 million (US$4.3 million) and earnings before income taxes was RMB28.2 million (US$4.3 million), respectively, in the first quarter of 2011, representing decreases of 52.4% and 53.1%, respectively, from the first quarter of 2010, and decreases of 44.9% and 45.3%, respectively, from the fourth quarter of 2010.

Net Income Attributable to Chemspec International Limited Shareholders

Net income attributable to Chemspec International Limited was RMB22.6 million (US$3.5 million), representing a decrease of 56.8% from the first quarter of 2010 and of 50.1% from the fourth quarter of 2010, respectively.

Basic and diluted earnings per ADS were RMB0.63 (US$0.10), as compared to RMB1.44 (US$0.21) in the first quarter of 2010 and RMB1.26 (US$0.19), in the fourth quarter of 2010.

Conference Call

The Company will not host a conference call for the first quarter of 2011 financial results.

Statement Regarding Unaudited Financial Information

The financial information set forth above is based on the Company's unaudited interim consolidated financial statements and is subject to adjustments that may be identified by us and/or our auditors during the audit of our annual consolidated financial statements.

About Chemspec

Chemspec is a leading China-based contract manufacturer of highly engineered specialty chemicals, especially, the fluorinated specialty chemicals. In manufacturing specialty chemicals, Chemspec also provides process design and process development services, which enable efficient and rapid production of specialty chemicals that are incorporated into the products of Chemspec's end users. Chemspec's customers and end users include electronics, pharmaceutical and agrochemical companies. For more information, please visit www.chemspec.com.cn.

Safe Harbor Statements

This announcement contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in Chemspec's filings with the U.S. Securities and Exchange Commission, as amended from time to time. Chemspec does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

For further information, please contact:

Chemspec International Ltd.
In Shanghai
Carol Fang
Manager, Investor Relations
Tel: +86-21-63638108
Email: ir@chemspec.com.cn

Chemspec International Limited

 

 

Unaudited Consolidated Balance Sheets

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

March 31,

 

 

March 31,

 

 

 

2010

 

 

2011

 

 

2011

 

 

 

RMB'000

 

 

RMB'000

 

 

USD'000

 

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

Cash

 

98,719

 

 

74,385

 

 

11,359

 

 

Pledged bank deposits

 

56,746

 

 

44,303

 

 

6,766

 

 

Accounts receivable, net

 

137,873

 

 

95,664

 

 

14,609

 

 

Bills receivable

 

1,200

 

 

150

 

 

23

 

 

Inventories

 

470,432

 

 

464,991

 

 

71,010

 

 

Prepayment and other receivables

 

73,449

 

 

60,267

 

 

9,203

 

 

Income tax recoverable

 

-

 

 

1,454

 

 

222

 

 

Deferred income tax assets

 

6,369

 

 

8,305

 

 

1,268

 

 

Total current assets

 

844,788

 

 

749,519

 

 

114,460

 

 

Property, plant and equipment, net

 

871,398

 

 

869,612

 

 

132,800

 

 

Land use rights

 

59,201

 

 

58,864

 

 

8,989

 

 

Deposit for purchases of intangible assets

 

-

 

 

9,000

 

 

1,374

 

 

Deposit for purchases of other investment

 

-

 

 

5,000

 

 

764

 

 

Intangible assets

 

730

 

 

703

 

 

107

 

 

Goodwill

 

7,446

 

 

7,446

 

 

1,137

 

 

Investment in an affiliate

 

12,793

 

 

12,668

 

 

1,935

 

 

Cost-method investment

 

-

 

 

25,026

 

 

3,822

 

 

Total assets

 

1,796,356

 

 

1,737,838

 

 

265,388

 

 

 

 

 

 

 

 

 

LIABILITIES AND EQUITY

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

Bank borrowings

 

25,000

 

 

25,000

 

 

3,818

 

 

Accounts payable

 

142,319

 

 

111,460

 

 

17,022

 

 

Bills payable

 

64,340

 

 

52,994

 

 

8,093

 

 

Accrued expenses and other payables

 

148,238

 

 

89,376

 

 

13,649

 

 

Amounts due to related parties

 

5,559

 

 

58

 

 

9

 

 

Deferred income

 

14,215

 

 

16,315

 

 

2,491

 

 

Income taxes payable

 

5,408

 

 

-

 

 

-

 

 

Total current liabilities

 

405,079

 

 

295,203

 

 

45,082

 

 

Bank borrowings

 

-

 

 

30,000

 

 

4,581

 

 

Deferred income tax liabilities

 

21,517

 

 

22,043

 

 

3,366

 

 

Deferred income

 

3,280

 

 

1,380

 

 

211

 

 

Total liabilities

 

429,876

 

 

348,626

 

 

53,240

 

 

Equity

 

 

 

 

 

 

 

Equity attributable to Chemspec International Limited

 

 

 

 

 

 

 

Ordinary shares:
   Par value: HK$ 0.01;
   Authorized: 20,000,000,000 shares
   as of December 31, 2010 and March 31,
   2011;
   Issued and outstanding:
   2,163,190,740 shares
   as of  December 31, 2010 and
  March 31, 2011;

 

21,649

 

 

21,649

 

 

3,306

 

 

Additional paid-in capital

 

319,048

 

 

320,370

 

 

48,924

 

 

Statutory reserves

 

85,820

 

 

85,820

 

 

13,106

 

 

Accumulated other comprehensive income

 

5,197

 

 

5,037

 

 

769

 

 

Retained earnings

 

929,108

 

 

951,726

 

 

145,339

 

 

Equity attributable to Chemspec International Limited

 

 

 

 

 

 

 

1,360,822

 

 

1,384,602

 

 

211,444

 

 

Noncontrolling interests

 

5,658

 

 

4,610

 

 

704

 

 

 

 

 

 

 

 

 

Total equity

 

1,366,480

 

 

1,389,212

 

 

212,148

 

 

Total liabilities and equity

 

1,796,356

 

 

1,737,838

 

 

265,388

 

 

 

 

 

 

 

 



Chemspec International Limited

 

 

Unaudited Quarterly Consolidated Statements of Income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-month periods ended

 

 

 

 

 

March 31,

 

 

December 31,

 

 

Mar 31,

 

 

Mar 31,

 

 

 

 

 

2010

 

 

2010

 

 

2011

 

 

2011

 

 

 

 

 

RMB'000

 

 

RMB'000

 

 

RMB'000

 

 

USD'000

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

 

 

 

220,151

 

 

270,357

 

 

208,967

 

 

31,912

 

 

Cost of sales

 

 

(123,813)

 

 

(171,629)

 

 

(132,139)

 

 

(20,179)

 

 

Gross profit

 

 

96,338

 

 

98,728

 

 

76,828

 

 

11,733

 

 

Selling expenses

 

 

(2,503)

 

 

(3,083)

 

 

(4,295)

 

 

(656)

 

 

General and administrative expenses

 

 

(20,761)

 

 

(23,719)

 

 

(32,170)

 

 

(4,914)

 

 

Research and development expenses

 

 

(13,705)

 

 

(22,129)

 

 

(11,952)

 

 

(1,825)

 

 

Other operating expenses

 

 

(551)

 

 

(1,205)

 

 

(204)

 

 

(31)

 

 

Other operating income

 

 

509

 

 

351

 

 

242

 

 

37

 

 

Government grants

 

 

450

 

 

2,684

 

 

-

 

 

-

 

 

Income from operations

 

 

59,777

 

 

51,627

 

 

28,449

 

 

4,344

 

 

Other income (expenses):

 

 

 

 

 

 

 

 

 

 

Interest income

 

 

558

 

 

525

 

 

471

 

 

72

 

 

Interest expense

 

 

(80)

 

 

-

 

 

(295)

 

 

(45)

 

 

Foreign currency exchange loss, net

 

 

(47)

 

 

(583)

 

 

(388)

 

 

(59)

 

 

Equity in loss of an affiliate

 

 

(98)

 

 

(150)

 

 

(125)

 

 

(19)

 

 

Other income

 

 

48

 

 

142

 

 

73

 

 

11

 

 

Earnings before income taxes

 

 

60,158

 

 

51,561

 

 

28,185

 

 

4,304

 

 

 

 

 

 

 

 

 

 

 

 

 

Income tax expense

 

 

(7,718)

 

 

(6,408)

 

 

(5,815)

 

 

(888)

 

 

Net income

 

 

52,440

 

 

45,153

 

 

22,370

 

 

3,416

 

 

Net (income) loss attributable to
   noncontrolling interests

 

 

 

 

 

 

 

 

 

 

 

(127)

 

 

141

 

 

248

 

 

38

 

 

Net income attributable to Chemspec
   International Limited shareholders

 

 

 

 

 

 

 

 

 

 

 

52,313

 

 

45,294

 

 

22,618

 

 

3,454

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per share

 

 

RMB 0.02

 

 

RMB 0.02

 

 

RMB 0.01

 

 

USD 0.00

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share

 

 

RMB 0.02

 

 

RMB 0.02

 

 

RMB 0.01

 

 

USD 0.00

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per ADS

 

 

RMB 1.44

 

 

RMB 1.26

 

 

RMB 0.63

 

 

USD 0.10

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per ADS

 

 

RMB 1.44

 

 

RMB 1.26

 

 

RMB 0.63

 

 

USD 0.10

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



Chemspec International Limited

 

 

Unaudited Consolidated Statements of Cash Flows

 

 

 

 

 

 

 

 

 

 

March 31,

 

 

March 31,

 

 

March 31,

 

 

 

2010

 

 

2011

 

 

2011

 

 

 

RMB'000

 

 

RMB'000

 

 

USD '000

 

 

 

 

 

 

 

 

 

Cash flows from operating activities

 

 

 

 

 

 

 

Net income

 

52,440

 

 

22,370

 

 

3,416

 

 

Adjustments to reconcile net income to net cash

 

 

 

 

 

 

 

  provided by operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

 

 

 

 

 

 

of property, plant and equipment

 

17,358

 

 

21,771

 

 

3,325

 

 

Land use rights expenses

 

315

 

 

337

 

 

51

 

 

Loss on disposal of property, plant and equipment

 

188

 

 

162

 

 

25

 

 

Amortization of intangible assets

 

28

 

 

27

 

 

4

 

 

Equity in loss of an affiliate

 

98

 

 

125

 

 

19

 

 

Unrealized foreign exchange loss, net

 

32

 

 

248

 

 

38

 

 

Share-based compensation

 

1,872

 

 

1,322

 

 

202

 

 

Deferred income tax benefit

 

(1,651)

 

 

(1,410)

 

 

(215)

 

 

Changes in operating assets and liabilities, net of

 

 

 

 

 

 

 

  effect of an acquisition

 

 

 

 

 

 

 

Pledged bank deposits related to purchase of inventories

 

(26,164)

 

 

14,189

 

 

2,167

 

 

Inventories

 

(54,285)

 

 

5,441

 

 

831

 

 

Accounts receivable

 

(19,992)

 

 

41,958

 

 

6,407

 

 

Bills receivable

 

1,279

 

 

1,050

 

 

160

 

 

Prepayment and other receivables

 

(8,172)

 

 

4,182

 

 

639

 

 

Accounts payable

 

22,072

 

 

(30,859)

 

 

(4,713)

 

 

Bills payable related to purchase of inventories

 

17,904

 

 

(12,850)

 

 

(1,962)

 

 

Accrued expenses and other payables

 

(4,371)

 

 

6,416

 

 

980

 

 

Deferred income

 

1,001

 

 

200

 

 

31

 

 

Income taxes payable

 

298

 

 

(6,862)

 

 

(1,048)

 

 

Net cash provided by operating activities

 

250

 

 

67,817

 

 

10,357

 

 

 

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

 

 

 

Capital expenditures, including interest capitalized

 

(76,552)

 

 

(83,921)

 

 

(12,815)

 

 

Pledged bank deposits related to purchase of property,

 

 

 

 

 

 

 

  plant and equipment

 

(1,542)

 

 

(1,746)

 

 

(267)

 

 

Payments for land use rights

 

(400)

 

 

-

 

 

-

 

 

Deposit for purchase of other investment

 

-

 

 

(5,000)

 

 

(764)

 

 

Purchase of investment

 

-

 

 

(25,026)

 

 

(3,822)

 

 

Net cash used in investing activities

 

(78,494)

 

 

(115,693)

 

 

(17,668)

 

 

 

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

 

 

Dividend by a subsidiary to
  noncontrolling shareholders

 

 

 

 

 

 

 

-

 

 

(800)

 

 

(122)

 

 

Acquisition of additional equity interest in subsidiaries
  from noncontrolling interests

 

 

 

 

 

 

 

(26,300)

 

 

-

 

 

-

 

 

Proceeds from long-term bank borrowings

 

-

 

 

30,000

 

 

4,581

 

 

Repayments of  long-term bank borrowings

 

(5,000)

 

 

-

 

 

-

 

 

Repayments of non-interest bearing borrowings

 

 

 

 

 

 

 

  from related parties

 

(1,000)

 

 

(5,500)

 

 

(840)

 

 

Net cash (used in) provided by financing activities

 

(32,300)

 

 

23,700

 

 

3,619

 

 

 

 

 

 

 

 

 

Effect of foreign currency exchange rate changes

 

 

 

 

 

 

 

   on cash

 

(19)

 

 

(158)

 

 

(24)

 

 

 

 

 

 

 

 

 

Net decrease in cash

 

(110,563)

 

 

(24,334)

 

 

(3,716)

 

 

Cash at beginning of year

 

351,097

 

 

98,719

 

 

15,075

 

 

Cash at end of year

 

240,534

 

 

74,385

 

 

11,359

 

 

 

 

 

 

 

 

 

Supplemental disclosures of cash flow information:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income taxes paid

 

9,071

 

 

14,087

 

 

2,151

 

 

Interest paid, net of amounts capitalized

 

80

 

 

295

 

 

45

 

 

 

 

 

 

 

 

 

Noncash investing and financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Payable for purchase of property, plant and equipment

 

86,848

 

 

64,045

 

 

9,780

 

 

Payable for acquisition of Kangpeng Nong Hua

 

25,000

 

 

-

 

 

-

 

 

Bills payable for purchase of property, plant and equipment

 

20,751

 

 

21,401

 

 

3,268

 

 

 

 

 

 

 

 




 

Source: Chemspec International Limited
Related Stocks:
NYSE:CPC
collection